Larson Financial Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
Larson Financial Group's NEO Position: Q3 2026 in Review
Larson Financial Group increased its NeoGenomics (NEO) stake by 179% in Q3 2026, buying an estimated $1.01K and bringing the position to 95 shares worth $1.74K. The position accounts for ﹤0.01% of the portfolio, ranked #3255.
Larson Financial Group first reported a position in NEO in Q2 2024 and has held it in 10 quarters since. The position peaked at $4.27K in Q4 2025. 259 funds tracked by Wall St. Rank hold NEO as of Q3 2026.
- Larson Financial Group held 95 shares of NeoGenomics worth $1.74K as of Q3 2026.
- Larson Financial Group bought 61 NeoGenomics shares in Q3 2026, an estimated $1.01K.
- NeoGenomics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3255 holding.
- Larson Financial Group first reported a position in NeoGenomics in Q2 2024 and has held it in 10 quarters since.
- Larson Financial Group's NeoGenomics position peaked at $4.27K in Q4 2025.
- 259 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.